Clinical Trial: A Study to Investigate the Efficacy and Safety of GSK5784283 Compared With Placebo in Participants With Uncontrolled Asthma (PERSIST ASTHMA-2)

U.S., Aug. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07782996) titled 'A Study to Investigate the Efficacy and Safety of GSK5784283 Compared With Placebo in Participants With Uncontrolled Asthma (PERSIST ASTHMA-2)' on Aug. 20.

Brief Summary: The study aims to demonstrate the superiority of GSK5784283 compared to placebo in reducing the annualized rate of clinically meaningful asthma exacerbations.

Study Start Date: Aug. 31

Study Type: INTERVENTIONAL

Condition: Asthma

Intervention: DRUG: GSK5784283

GSK5784283 will be administered.

DRUG: Placebo

Placebo will be administered.

DRUG: Standard of care

Standard of care will be administered.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: GlaxoSmi...